Navigation Links
Shorter infants have lower incomes in later life

British researchers have found evidence that male babies who grow slowly in their first year of life have lower incomes in later life. The results hold true regardless of the socioeconomic status of the child's family, suggesting that slow infant growth may be accompanied by hampered brain development. Biological processes linked to poor growth in infancy lead to lifelong impairment of cognitive function with consequent lower //occupational status and income.

Researcers at the National Public Health Institute in Helsinki, Finland studied 4,630 men born in Helsinki between 1934 and 1944. The height of each man had been measured an average of 18 times between birth and age 12, measurements that the researchers linked to records of their level of education, information about income and occupation taken from the 1990 census.

The researchers divided the men into six groups according to their length at age one. Men in the lowest group -- under 72 centimetres, or 28 inches, at one year earned an average annual salary equivalent to only about 75% of what men in the highest group, longer than 80 centimetres or 31 inches at age one, earned.

Weight at one year in boys predicts their cognitive function. Boys who grow better between birth and one have better educational achievements and they make more money when they're fifty. Since, in a democratic society, income is a test of cognitive function among other things, this is rather a striking demonstration of the critical period of growth between birth and one year.
'"/>




Page: 1

Related medicine news :

1. Eye Disorders, A Predictor Of A Shorter Lifespan
2. Shorter Radiation Schedules Found To Be More Effective For Patients With Breast Cancer
3. Shorter Post-Operative Recovery Stay After Tonsillectomy for Kids Safe, Cost-Efficient
4. People With More Kids may Have Shorter Life Span
5. Longer Sleep Could Mean Shorter Life Span
6. New Research May Pave the Way for Shorter Hospital Stays for Diabetes Patients
7. Sedentary Lives Equal Shorter ‘sweeter’ Livs
8. Developmental, neurologic problems common in extremely preterm infants
9. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
10. CDC reveals relationship between prepregnant weight and heart defects in infants
11. Erythromycin and infants’ intestinal disorde
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: